Stock screener

MDWD

SetupConviction 28LongHealthcareScan · Fri, Sep 25, 2026
Flat basebase

MediWound Ltd. (MDWD) closed at $13.86 (+0.18%) on Sep 25, 2026. It is in the "Setting up" lane with a flat base pattern. Price is above its 50-day and below its 200-day moving average. RSI(14) 55, RS Rating 18, -29.6% from its 52-week high, -24.8% year to date. Sector: Healthcare · Biotechnology.

MDWD$13.86+0.18%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
2
2
Vol MA14 103.78K
Jun 29Jul 16Aug 4Aug 20Sep 9Sep 25

Trade plan

LongReward : Risk1.49
Entry
Entry
14.07
Risk
Stop
13.32
-5.3% to stop
Reward
Target 1
15.19
+8.0% to target
Stretch
Target 2
16.31
+15.9% to T2
Risk : reward balance
Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

MediWound Ltd.Biotechnologywww.mediwound.com ↗
Price13.86
Change+0.18%
Gap+0.87%
Rel volume0.85×
Avg volume110.02K
Avg $ vol1.47M
SMA 2013.37
SMA 5013.69
SMA 20015.96
Price vs 50+1.20%
Price vs 200-13.16%
MA stackmixed
50/200 cross—
Supertrenddown · 14.14
RSI (14)55
MACD hist0.09
MACD cross—
Stoch %K / %D81 / 75
ADX (14)16
+DI / −DI19 / 13
RSI divergence—
MACD divergenceBearish
ATR %3.62%
ADR %3.79%
52w high19.69
52w low12.61
From 52w high-29.63%
Above 52w low+9.87%
New 52w highNo
SqueezeOff
Bollinger width12.22%
%B0.79
Donchian pos86.13%
Donchian high14.07
Donchian low12.52
AVWAP (52w high)16.15
vs AVWAP high-14.21%
AVWAP (52w low)13.34
vs AVWAP low+3.88%
OBV trendUp
Chaikin MF (20)0.10
Today vs 20d0.85×
Avg vol (14d)105.56K
Avg vol (20d)110.02K
Avg $ vol (20d)1.47M
Market cap177.83M
RS Rating18 / 99
RS 3m (vs SPY)-14.60%
RS 6m (vs SPY)-31.38%
RS line new highNo
Trend template1/8
Technical rank45.3
1 week+3.40%
1 month+9.09%
3 months-8.79%
6 months-11.81%
1 year-23.11%
YTD-24.78%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target29.60
Target upside113.64%
Analyst ratingBuy
Institutional48.36%
Ent. value177.83M
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryBiotechnology
ExchangeNasdaq
Shares out12.85M
Employees121
ListedThu, Mar 20, 2014
Free float9.59M
Float %74.9%
Short interest1.63M
Days to cover14.4d
Short volume78.2%
Squeeze score79 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.77 vs −$0.76
Last surprise-1.3% miss
Setup gradeD
Conviction28 / 100
Pattern quality71%
Tech rank45.3 / 100
Group rank50 / 100
Status laneSetting up
Setup directionLong
Pattern familyBase
Resistance14.07
Support12.95
Days since event—
Candle confirm—

Congress activity

Disclosed STOCK Act trades in MDWD

All disclosures →
No recent disclosed trades by Congress in MDWD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MDWD · open-market 3 buys · 4 sells

InsiderSideShares
Rubinstein Samuel
Director · Ordinary Shares · 2026-09-01
Buy525
Rubinstein Samuel
Director · Ordinary Shares · 2026-09-01
Sell525
Hess Shmuel
COO & Chief Commercial Officer · Ordinary Shares · 2026-08-27
Sell1.98K
Hess Shmuel
COO & Chief Commercial Officer · Stock Option (right to buy ordinary shares) · 2026-08-27
Exercise11K
Hess Shmuel
COO & Chief Commercial Officer · Ordinary Shares · 2026-08-27
Sell1.98K
Hess Shmuel
COO & Chief Commercial Officer · Ordinary Shares · 2026-08-26
Sell1.86K
Hess Shmuel
COO & Chief Commercial Officer · Stock Option (right to buy ordinary shares) · 2026-08-26
Exercise5K
SHAMIR NACHUM
Director · Ordinary Shares · 2026-06-03
Buy175
SHAMIR NACHUM
Director · Ordinary shares · 2026-06-03
Other—
SHAMIR NACHUM
Director · Ordinary Shares · 2026-06-03
Buy5.83K

SEC filings

EDGAR filings in MDWD · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.